Bone Therapeutics and Medsenic set to combine in share for share deal
Subject to the outcome of a shareholders’ meeting, Bone Therapeutics and Medsenic are set to…
August 10, 2022 - 3 minutes
Immunotherapy
Genmab and BioNTech expand collaboration to develop and commercialize immunotherapy candidates
A collaboration between Genmab and BioNTech to develop and commercialize immunotherapies for the treatment of…
August 8, 2022 - 2 minutes
Success across the board for C4X Discovery Holdings plc and its partnerships
Drug discovery company C4X Discovery Holdings plc released a report today (August 2) detailing the continued…
August 2, 2022 - 3 minutes
Cancer patients enrolled on study to predict immunotherapy response
An observational study has started enrolling patients with advanced/metastatic non-small cell lung cancer (NSCLC). Florida-based…
July 29, 2022 - 3 minutes
Kelun-Biotech announces joint license agreement with MSD for drug targeting solid tumors
Kelun-Biotech and MSD (Merck & Co.) have announced they are entering in a joint license…
July 28, 2022 - 3 minutes
Valo Therapeutics acquires PeptiCHIP technology to identify tumor antigens
Finnish immunotherapy company Valo Therapeutics Oy (ValoTx) has obtained exclusive licensing of intellectual property rights…
July 26, 2022 - 2 minutes
Trial for drug targeting cancerous tumors begins in China
A phase 1 trial to investigate a drug for treating people with advanced malignant neoplasms…
July 18, 2022 - 3 minutes
First patient receives new immunotherapy drug for HIV in clinical trial
A new class of bispecific protein immunotherapy, being developed for patients with human immunodeficiency virus…
July 12, 2022 - 3 minutes
AI being used to perform molecular analysis of biopsies from bowel disease patients
Artificial intelligence will be used to perform molecular analysis of biopsies from unidentified Inflammatory Bowel…
July 12, 2022 - 2 minutes
Cancer therapeutics company’s double win with $25M funding, and appointment of new board member
An mRNA-technology company developing cancer therapeutics designed to improve patients' survival rate and quality of…
July 8, 2022 - 3 minutes
Evotec completes acquisition of Rigenerand
An Italian-based cell therapy business has just been bought by Evotec SE, a German therapeutics…
July 5, 2022 - 3 minutes
Funding doubled for company working on breakthrough auto-immune disease therapeutics
A Paris-based biotech company developing products for auto-immune diseases, announced today (June 30) that it…
June 30, 2022 - 3 minutes
